Sevelamer carbonateMeSH concept

https://www.has-sante.fr/jcms/p_3163607
2020
France
evaluation of the transparency committee
Sevelamer
sevelamer carbonate

---
https://www.has-sante.fr/jcms/p_3161193/fr/renvela
2020
false
false
false
France
sevelamer
sevelamer carbonate
chelating agents
administration, oral
insurance, health, reimbursement
treatment outcome
child
hyperphosphatemia
Renal failure-associated hyperphosphatemia (disorder)
evaluation of the transparency committee
Sevelamer

---
https://www.ema.europa.eu/medicines/human/EPAR/Sevelamer-carbonate-Zentiva
2015
false
United Kingdom
English
French
treatment outcome
drug evaluation
sevelamer carbonate
sevelamer carbonate
hyperphosphatemia
syndication feed
Sevelamer
Sevelamer
drug approval
drug labeling
adult
renal dialysis
peritoneal dialysis
chelating agents
chelating agents
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
administration, oral
renal insufficiency, chronic
sevelamer
package leaflet
summary of product characteristics

---
https://www.ema.europa.eu/medicines/human/EPAR/Renvela
2012
false
United Kingdom
English
French
sevelamer carbonate
sevelamer carbonate
hyperphosphatemia
syndication feed
Sevelamer
Sevelamer
drug approval
drug labeling
adult
renal dialysis
peritoneal dialysis
chelating agents
chelating agents
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
administration, oral
renal insufficiency, chronic
sevelamer
package leaflet
summary of product characteristics

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-11/renvela_-_ct-7124.pdf
http://www.has-sante.fr/portail/jcms/c_874879/renvela
2009
false
France
French
evaluation of the transparency committee
Sevelamer
sevelamer carbonate
renal dialysis
adult
treatment outcome
administration, oral
hyperphosphatemia
renal insufficiency, chronic
chelating agents
sevelamer
insurance, health, reimbursement
polyamines

---